Ascend Laboratories, Llc, Metoprolol Succinate Extended-release Tablets, Usp, 25 Mg*

Metoprolol Succinate Recall Summary Ascend Laboratories is recalling Metoprolol Succinate Extended-Release Tablets, 25 mg, distributed nationwide because the medication failed to meet dissolution specifications, meaning the tablets may not break down in the body as intended. This recall affects patients across all U.S. states and the District of Columbia who received this blood pressure medication. The affected product was manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories in New Jersey.

Recalling firm

Ascend Laboratories, LLC

Product

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Reason

Failed Dissolution Specifications

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-04-27

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

U.S. Nationwide

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/fd3247e9-6938-48a1-9282-8b79d77998cc